US experts urged regulators Wednesday to approve a second new anti-cholesterol drug, a day after recommending they bring to market the first in a new class of medications to lower the risk of heart attack.
Virologists making mutated versions of the H5N1 bird flu halted their research in January after a U.S. government advisory panel suggested that their work, though well-intentioned, had the potential to endanger the public.
International scientists who last year halted controversial research with the deadly bird flu say they are resuming their work as countries adopt new rules to ensure safety.
In a top-security lab in the Netherlands, scientists guard specimens of a super-killer influenza that slays half of those it infects and spreads easily from victim to victim.
The latest word from an advisory panel that helps form U.S. dietary guidelines confirms what nutritionists have been saying in recent years: Cholesterol-rich foods like eggs and shrimp aren't as bad for us ...
(HealthDay)—A U.S. Food and Drug Administration advisory panel met Thursday and Friday to discuss the fate of certain painkillers that contain the opioid known as hydrocodone, concluding in a vote in favor ...
(HealthDay)—A U.S. Food and Drug Administration advisory panel voted Friday to place tougher restrictions on prescription painkillers containing hydrocodone, potentially moving medications such as Vicodin ...
(HealthDay)—When it comes to the care of your children's teeth, dentists aren't the only experts who can help.
The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.
(HealthDay)—A U.S. Food and Drug Administration advisory panel will meet Thursday and Friday to discuss the fate of certain painkillers that contain an opioid known as hydrocodone.
(HealthDay) -- A leading U.S. government advisory panel has proposed that postmenopausal women not take low-dose calcium and vitamin D supplements daily to ward off bone fractures.
US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.
(HealthDay) -- A top U.S. advisory panel has recommended against preventive electrocardiography (EKG) screening for people at low risk of heart disease.
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
A government advisory panel is considering whether the anthrax vaccine should be tested in children.